|
Originally published In Press as doi:10.1074/jbc.M106693200 on September 10, 2001
J. Biol. Chem., Vol. 276, Issue 48, 44541-44550, November 30, 2001
A Comparison of the GroE Chaperonin Requirements for Sequentially
and Structurally Homologous Malate Dehydrogenases
THE IMPORTANCE OF FOLDING KINETICS AND SOLUTION ENVIRONMENT*
Bryan C.
Tieman ,
Mary F.
Johnston, and
Mark T.
Fisher§
From the Department of Biochemistry and Molecular Biology,
University of Kansas Medical Center,
Kansas City, Kansas 66160-7421
Received for publication, July 16, 2001, and in revised form, September 7, 2001
 |
ABSTRACT |
Escherichia coli malate
dehydrogenase (EcMDH) and its eukaryotic counterpart, porcine
mitochondrial malate dehydrogenase (PmMDH), are highly homologous
proteins with significant sequence identity (60%) and virtually
identical native structural folds. Despite this homology, EcMDH folds
rapidly and efficiently in vitro and does not seem to
interact with GroE chaperonins at physiological temperatures
(37 °C), whereas PmMDH folds much slower than EcMDH and requires
these chaperonins to fold to the native state at 37 °C. Double jump
experiments indicate that the slow folding behavior of PmMDH is not
limited by proline isomerization. Although the folding enhancer
glycerol (<5 M) does not alter the renaturation kinetics
of EcMDH, it dramatically accelerates the spontaneous renaturation of PmMDH at all temperatures tested. Kinetic
analysis of PmMDH renaturation with increasing glycerol concentrations suggests that this osmolyte increases the on-pathway kinetics of the
monomer folding to assembly-competent forms. Other osmolytes such
as trimethylamine N-oxide, sucrose, and betaine also
reactivate PmMDH at nonpermissive temperatures (37 °C).
Glycerol jump experiments with preformed GroEL·PmMDH complexes
indicate that the shift between stringent (requires ATP and GroES) and
relaxed (only requires ATP) complex conformations is rapid (<3-5 s).
The similarity in irreversible misfolding kinetics of PmMDH measured
with glycerol or the activated chaperonin complex (GroEL·GroES·ATP)
suggests that these folding aids may influence the same step in the
PmMDH folding reaction. Moreover, the interactions between
glycerol-induced PmMDH folding intermediates and GroEL·GroES·ATP
are diminished. Our results support the notion that the protein folding
kinetics of sequentially and structurally homologous proteins, rather
than the structural fold, dictates the GroE chaperonin requirement.
 |
INTRODUCTION |
GroEL is a complex, allosteric, protein folding machine whose
function is controlled by associations with nucleotides, the co-chaperonin GroES, and substrate polypeptides (1-3). As with all
allosteric proteins, ligand binding influences the structural constraints within the system, which in turn ultimately induce shifts
between various functional states. Although detailed information is
available on the structures of GroEL, with and without bound nucleotide, and of one GroEL·GroES complex, the exact mechanism(s) explaining chaperonin-assisted folding of substrate proteins remain(s) unclear. Differences in binding and conditions for productive release
of substrate proteins are routinely observed, but the structural and
energetic basis of these differences is not understood at the molecular
level. Although molten globule folding intermediates have been
suggested to be preferred substrates for chaperonins, the structures of
these intermediate populations have broad distributions thus making it
difficult to identify specific transient conformations that interact
with the GroE chaperonins.
In vitro and in vivo studies have shown that many
proteins can interact with and fold from the chaperonin system, but the chaperonin requirements are highly variable. For instance, some proteins require the full complement of GroEL, GroES, and ATP to fold
at physiological temperatures, whereas under the same conditions, other
proteins have folded to high yields with only GroEL and ATP. It has
been observed that a number of structurally homologous isozymes show
differences in their chaperonin requirements. In an effort to explain
the origins of these differences, Clarke and co-workers (4) have
compared the chaperonin requirements for the structurally homologous
cytoplasmic and mitochondrial malate dehydrogenases. They have found
that the increase in chaperonin requirements of the mitochondrial form
is correlated with an increase in its global hydrophobicity. In another
study, Martinez-Carrion and co-workers (5) have suggested that shifts
in chaperonin requirements between the mitochondrial and the
cytoplasmic forms of aspartate transaminase are correlated with shifts
in the global pI of the substrate. Frieden and co-workers (6), on the
other hand, have suggested that the differences in the chaperonin
interactions for structurally homologous murine and Escherichia
coli dihydrofolate reductases
(DHFR)1 may be the result of
additional extensions of omega loops present on the murine DHFR.
Although these correlations have been proposed to explain the
variability in chaperonin requirements for folding isozymes, none of
the correlations is generally applicable. For example, although the
increased hydrophobicity of mitochondrial MDH over cytoplasmic MDH has
been proposed to explain its stringent chaperonin requirements
(i.e. requiring GroEL, GroES, and ATP) (4), this correlation
does not hold for the cytoplasmic and mitochondrial isoforms of
aspartate transaminase (5). Likewise, the correlation of chaperonin
stringency with the basic pI of mitochondrial isozymes does not hold
because rhodanese, a highly stringent mitochondrial chaperonin
substrate, has a slightly acid pI. In addition, the potential
chaperonin substrate proteins identified from high affinity chaperonin-protein complexes isolated from E. coli cell
extracts have a wide range of global pI values (7). Furthermore, the role that specific folding motifs play in dictating interactions between mammalian DHFR and the chaperonin has been questioned recently
(8).
Rather than identifying correlations between chaperonin stringency and
primary sequences or native tertiary and quaternary structures of
homologous proteins, it appears that the folding kinetics and the
lifetime of the folding intermediates (9, 10) may be more reasonable
properties that ultimately define the chaperonin requirements. In more
recent work, Clark and Frieden (11, 12) provide strong evidence that
kinetic factors may indeed explain the differences in chaperonin
requirements for the homologous E. coli and mammalian DHFR
isozymes. Specifically, an intermediate population of mammalian DHFR,
existing as a partially folded species, can interact with the
chaperonin before refolding to the native conformation. Unfortunately,
these studies have only examined the interaction of the homologous DHFR
substrates with the nucleotide-free high affinity form of GroEL, a
species that may have very transient lifetimes in vivo. In
addition, the recent observation that the activated GroE species
(i.e. GroEL, GroES, and ATP) may actively unfold bound
substrates suggests that the high affinity form of GroEL represents an
oversimplification of chaperonin-substrate interaction (13). Thus, if
we are to understand the dynamic nature of the interactions between
chaperonins and their protein substrates, we must examine systems where
E. coli substrates and their homologous mitochondria
counterparts interact with more physiologically relevant, activated
chaperonin species.
In this work, we have compared the folding of a highly homologous pair
of malate dehydrogenase (MDH) enzymes, E. coli (EcMDH) and
porcine mitochondria (PmMDH), in the absence and presence of the GroE
chaperonins. The correlative studies of Hartl and co-workers (7)
indicate that intrinsic GroEL polypeptide substrates contain
predominantly  tertiary folds containing two or more domains.
PmMDH has this same type of fold and has been suggested to be a model
in vitro substrate of the bacterial GroE chaperonins. The
homologous PmMDH and EcMDH proteins in our study fold within cellular
environments that contain group I chaperonins (GroEL/GroES in E. coli and Hsp60/Hsp10 in mitochondria). In addition, these two
isozymes are more highly related to each other than any other homologous proteins used to study chaperonin interactions.
In the absence of chaperonins, EcMDH has been found to reactivate much
more rapidly than PmMDH at 25 °C (14). In this study, we have
examined the refolding of EcMDH at a physiological temperature of
37 °C to determine whether EcMDH will now require chaperonins to aid
in its folding. Although PmMDH and EcMDH are highly similar with
respect to sequence and structure (~60% sequence identity, ~80%
sequence similarity), we find no evidence that EcMDH binds to or even
interacts with the activated chaperonin complex (GroEL·GroES·ATP). Because the renaturation rate and probably the folding speed of EcMDH
are more rapid, an increase in the folding of PmMDH should also
diminish the chaperonin requirement.
Numerous investigators have found that including polyols in the
refolding buffer can lead to increased protein refolding rates (15,
16). We have found that the inclusion of the osmolyte, glycerol, in the
refolding buffer leads to an enormous increase in both yield and
reactivation rate of PmMDH at all temperatures tested. Under these
conditions, the initial interactions between the refolding PmMDH
subunits and the activated GroE chaperonin complex are no longer
detectable. These studies suggest that the folding kinetics of the
protein, rather than its particular structural fold, dictates the
observed variability in chaperonin interactions with structurally
homologous isozymes.
 |
MATERIALS AND METHODS |
The GroE Molecular Chaperonins, GroEL and GroES--
The
E. coli chaperonins, GroEL and GroES, were isolated from the
lysate of cells containing the appropriate overexpression plasmid
(gifts from Dr. Edward Eisenstein and Dr. George Lorimer, respectively). GroEL and GroES were purified as described by Voziyan and Fisher (17) and Eisenstein et al. (18). Because GroEL and GroES do not contain tryptophan residues, the removal of
tryptophan-containing contaminants, as assayed by second derivative
analysis of the absorption spectra and tryptophan fluorescence, was
used as a criterion for purity of the chaperonin preparations as well
as by silver-stained SDS-polyacrylamide gel electrophoresis (19).
Anti-GroEL Antibodies--
Polyclonal IgG antibodies reactive to
GroEL were purified from the sera of rabbits immunized with purified
GroEL (20). A 1:1 solution of sera and the provided binding buffer at a
physiological pH (pH 7.5) was equilibrated with a protein A column
(Pierce Chemical Company). The protein A column was then washed with
3-5 column volumes of the binding buffer. The IgG was eluted with an
acidic elution buffer (pH 2.8), and the fractions were collected. The IgG fractions were dialyzed thoroughly against 50 mM
Tris-HCl, pH 7.5, and 0.5 mM (Na)2EDTA and
concentrated using Amicon Centricon-30 ultrafiltration units.
Malate Dehydrogenase--
PmMDH and EcMDH were purchased from
Sigma. The purity of each protein was examined by SDS-polyacrylamide
gel electrophoresis followed by a silver staining procedure to resolve
the protein bands. No foreign protein bands for PmMDH or EcMDH were observed.
Denaturation and Renaturation of MDH--
5 µM
PmMDH or EcMDH was first denatured in standard buffer (50 mM triethanolamine hydrochloride, 20 mM
MgCl2, 50 mM KCl, and 10 mM
dithiothreitol, pH 7.5 at 37 °C) containing 6 M
guanidine HCl or 8 M urea for at least 1-2 h at 0 °C on
ice, unless otherwise stated. Under these conditions, both isozymes
were unfolded completely as assessed by the complete loss of
activity. Complete unfolding of secondary and tertiary structures was
confirmed by both tyrosine fluorescence and near UV circular dichroism
spectroscopy (data not shown). Renaturation of a small aliquot of
concentrated MDH was initiated by a rapid 100-fold dilution of standard
buffer alone or with various combinations of 1 µM GroEL,
2 µM GroES, 5 mM ATP, and different
concentrations of glycerol. The final MDH subunit concentration was 0.1 µM, unless otherwise stated. ATP was added to the
refolding solution containing the GroE chaperonins 30-60 s before the
initiation of protein folding.
MDH Enzymatic Activity Assay--
The enzymatic activity of MDH
was determined at 37 °C using a substrate analog, ketomalonic acid
(1 mM), and 0.2 mM NADH under standard buffer
conditions, and following the rate of oxidation of NADH at 340 nm on an
Aminco SLM 3000 spectrophotometer (21, 22). The use of ketomalonic acid
as a competitive substrate for MDH eliminates the use of the natural
substrate oxaloacetate, which undergoes significant decarboxylation to
pyruvate at room temperature (22). The final MDH subunit concentration
in the assay mixture was between 0.05 and 0.09 µM. At
these MDH concentrations, for both EcMDH and PmMDH, the absorbance
decline of NADH was linear within the time range of the data
acquisition (1-3 min).
90° Light Scattering--
An SLM 8000S fluorescence
spectrophotometer with both the excitation and the emission wavelengths
set at 360 nm was used to measure the formation of protein aggregates
during the spontaneous renaturation of PmMDH with or without 35%
glycerol in standard buffer conditions at 37 °C. The bandpass for
the emission monochromator was set at 5 nm. The final PmMDH subunit
concentration in these experiments was 1 µM.
Proline Isomerization "Double Jump" Experiment--
The
double jump experiment was designed to detect the effect of proline
isomerization as it pertains to the renaturation kinetics of proteins
(23, 24). The term double jump refers to the change of
environment of a protein during the transition (i) from native to
denaturing solution conditions and (ii) from denaturing back to native
solution conditions. Native PmMDH was denatured at 20 °C for various
times from 30 s to 6 h before a rapid dilution with standard
buffer at 20 °C was performed to initiate spontaneous folding. In
these experiments, PmMDH was unfolded completely after 30 s as
determined by tyrosine fluorescence. The enzymatic activity of PmMDH
and EcMDH was used to monitor protein renaturation.
Commitment to the Native State--
The commitment experiments
were originally designed to examine the efficiency of the release of
protein substrates in either a native state or committed to fold to the
native state from chaperonin-substrate complexes (25). This methodology
was used to determine whether PmMDH folding intermediates could
interact with various components of the GroE chaperonin-mediated
protein folding mechanism (i.e. GroEL, GroES, and ATP) in
the presence and absence of 35% glycerol. In the presence and absence
of 35% glycerol, PmMDH renaturation was initiated either
spontaneously, with GroEL alone, with GroEL and ATP, or with GroEL,
GroES, and ATP at 37 °C in standard buffer conditions. Polyclonal
anti-GroEL antibodies were added to aliquots of renaturing protein at
15 s or nearly 2 h after the initiation of protein refolding.
The final concentration of solution components was as follows: PmMDH
monomers, 0.1 µM; GroEL, 1 µM; GroES, 2 µM; ATP, 5 mM; anti-GroEL antibodies, 50 µM. After the addition of anti-GroEL, the
immunoprecipitants were removed rapidly by spinning the mixture in a
microcentrifuge for 20-30 s. The supernatant was extracted, incubated
at 37 °C, and analyzed for enzymatic activity 2 h after the
initiation of refolding.
Irreversible Misfolding Kinetics--
To measure irreversible
misfolding rates, either the nucleotide-activated chaperonin complex
(GroEL· GroES·ATP) or 35% glycerol was added to samples of
refolding PmMDH at different times ranging from 0 to 60 s after
spontaneous folding was initiated in standard buffer at 37 °C
according to the protocol outlined by Voziyan et al. (33).
After the folding reaction took place for 4-6 h to reach maximum
refolding yields, the enzymatic activity of each sample was determined.
The final concentration of the solution components was as follows:
PmMDH monomers, 0.1 µM; GroEL, 1 µM; GroES,
2 µM; ATP, 5 mM.
Glycerol Jump Experiments--
PmMDH renaturation was initiated
at 0% or 35% glycerol in standard buffer with GroEL at 37 °C.
GroEL bound to the refolding protein and arrested its renaturation.
10 s or 60 min after folding was initiated, the glycerol
concentration was changed rapidly to either 35 or 3.5%, respectively,
with and without ATP. The final concentration of the solution
components was as follows: PmMDH monomers, 0.1 µM; GroEL,
1 µM; ATP, 5 mM. The renaturation of dimeric
PmMDH was monitored by the recovery of enzymatic activity.
Curve Fitting--
The renaturation data for PmMDH and EcMDH
were fit to two different models. PmMDH renaturation was modeled from
the folding reaction scheme of PmMDH as determined by Ranson et
al. (21). For PmMDH renaturation, a numerical analysis of the data
was performed with a software program developed by Micromath, Inc.,
Micromath Scientist for Windows, version 2.01. The protein folding
model and representative rate constants for the PmMDH folding scheme were as follows.
The rate constants associated with M U, N M, and Agg Iagg were assumed to be negligible. For EcMDH, the
renaturation data showed a better fit to a single exponential rise
(rather than a double exponential rise) using a nonlinear least squares procedure. However, the renaturation profiles of EcMDH observed when
GroEL alone was present were best fit to a double exponential rise. The
best fits were determined based on reduced 2 values and residuals.
 |
RESULTS |
Comparison of the Sequence and Structure of EcMDH and PmMDH--
A
comparison of the amino acid sequences between EcMDH and PmMDH reveals
a large degree of sequence identity and similarity, 58.2 and 80.3%,
respectively (Fig. 1A).
Functionally significant residues show even larger degrees of
conservation. For example, the subunit interfaces of the dimeric
structures are 74% identical (26). Hydropathy index (27) measurements
show that the mammalian mitochondrial form of MDH is more hydrophobic
than the mammalian cytoplasmic form (0.145 versus 0.035,
respectively). However, the hydropathy index of EcMDH (0.194) is more
similar to PmMDH, reflecting their high sequence identity and
similarity. On the other hand, the calculated theoretical pI of the
EcMDH (5.6) is similar to cytoplasmic MDH (5.91).

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 1.
Panel A, the sequence comparisons show
that these isozymes exhibit 58.2% sequence identity and 80.3%
sequence similarity. The top and bottom sequences
shown are EcMDH and PmMDH, respectively. Panel B, PmMDH
(gray lines) and EcMDH (black lines) are
structurally homologous (shown here as monomers). These structures were
generated using RasMol version 2.6-UCB (Glaxo Wellcome Ltd.) with PDB
files 1mld.pdb (PmMDH) and 2cmd.pdb (EcMDH).
|
|
A comparison of the three-dimensional, peptide backbone of the EcMDH
and PmMDH monomers reveals that these two proteins have identical folds
with very little variation (Fig. 1B). In contrast to the
differences observed with the EcDHFR and mitochondrial DHFR structures,
there are no extra loop structures present in the PmMDH compared with
the EcMDH (26, 28). Indeed, Banaszak and co-workers (26) have used the
partially refined structure of the porcine isoform to provide the
initial phases for solving the structure of the E. coli enzyme.
Refolding Reactions of EcMDH with PmMDH at Physiological
Temperatures in the Absence and Presence of Chaperonins--
Despite
the high degree of sequence and structural similarity, the bacterial
form folds much faster than its mitochondrial counterpart. The
refolding kinetics and chaperonin requirements for EcMDH and PmMDH were
compared under the same solution conditions at refolding temperatures
of 37 °C. Although both of these proteins can potentially interact
with a group I chaperonin family (i.e. GroE or Hsp60) in
their respective host organisms, it is clear that the EcMDH, under the
defined solution conditions, does not need the GroE chaperonin system
during refolding (Fig. 2A).
The renaturation kinetic profiles are virtually identical for
spontaneous refolding (refolding without chaperonins) or folding with
GroEL when either ATP or ATP and GroES are present. All three kinetic profiles showed optimal fits to a single exponential rise function (0.35 ± 0.01 s 1). When ATP is absent, the high
affinity nucleotide-free GroEL oligomer slows down the renaturation of
EcMDH, and the kinetic profile now fits a double exponential rise
(k1 = 0.0074 s 1 and
k2 = 0.00037 s 1). In all cases,
the activity yields of refolded protein are high (80-100% regain of
original activity).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Comparison of refolding EcMDH and PmMDH in
the absence and presence of chaperonins at 37 °C.
For both isozymes, folding is initiated by a 100-fold dilution of
concentrated MDH (5 µM) into refolding buffer. The
refolding buffer solutions for both sets of experiments contain 50 mM triethanolamine hydrochloride, 20 mM
MgCl2, 50 mM KCl, and 10 mM
dithiothreitol, pH 7.5, at 37 °C. The final monomeric concentrations
of MDH are 0.1 µM. The chaperonin concentrations are 1 µM GroEL oligomer, 2 µM GroES oligomer, and
5 mM ATP. In panel A the refolding of EcMDH is
examined in the absence of GroE chaperonins ( ), in the presence of
GroEL alone ( ), in the presence of GroEL and ATP ( ), and in the
presence of GroEL, GroES, and ATP ( ). The spontaneous refolding of
EcMDH was essentially as rapid (0.032 s 1) as the
refolding profiles with GroEL-ATP (0.048 s 1) and
GroEL·GroES·ATP (0.032 s 1) per a single exponential
function. The slower renaturation rate (fitted to a double exponential
function, k1 = 0.0073 s 1 and
k2 = 0.00037 s 1) is only observed
with GroEL alone. In panel B the same conditions and symbols
are illustrated as outlined in panel A. Here, the refolding
of PmMDH is only observed when GroEL, GroES, and ATP are present. The
kinetic parameters resulting in the best fit to the renaturation
profiles of PmMDH in the absence and presence of chaperonins are listed
in Table I.
|
|
In contrast, under exactly the same solution conditions, PmMDH
absolutely requires the complete chaperonin system, GroEL·GroES·ATP to refold and reactivate (Fig. 2B). No reactivation is
observed when refolding is initiated without the chaperonins present or when GroEL or GroEL and ATP are present. The chaperonin requirements of
PmMDH agree with previous studies (4, 29). In addition to the
differences in the chaperonin requirements, the refolding yields of
PmMDH are substantially lower (~60%) compared with the recoveries
observed with EcMDH (~90-100%). It is clear that the folding
mechanisms for these two proteins under these solution conditions are different.
Proline Isomerization and Folding of PmMDH--
Comparative
folding studies between homologous prokaryotic and eukaryotic aspartate
transaminase performed by Widmann and Christen (14) indicate that the
slower folding rate of the mitochondrial enzyme is caused, in part, by
differences in proline isomerization (14). A sequence comparison
between EcMDH and PmMDH reveals that there are more proline residues
present within the mitochondrial primary sequence than in its bacterial
homolog (21 versus 13 prolines, respectively). To test the
possibility that these additional proline residues are responsible for
the slower folding rate of PmMDH, we performed double jump experiments
(23, 24). Both EcMDH and PmMDH homologs undergo very rapid denaturation
when incubated in 6 M guanidine HCl. This unfolding
reaction is complete within 30 s as characterized by a complete
loss of native near UV CD and tyrosine fluorescence signals for both
EcMDH and PmMDH (data not shown). For comparative purposes, the double
jump experiments were performed at 20 °C where the renaturation of
PmMDH could be observed with ~50% recovery. At the shortest times of
incubation with a denaturant (30 s), there was only a slight increase
in the refolding rate (at t = 30 s,
k1 = 3.0 × 10 4
s 1 and k2 = 9.06 × 103 M 1 s 1) compared
with the refolding rates observed following a typical long term
denaturation (t = 2 h, k1 = 4.9 × 10 3 s 1 and
k2 = 4.0 × 103
M 1 s 1) (Fig.
3). Although there was a slight increase
in k1 when the PmMDH denaturation time was
decreased to 30 s, these kinetic data indicate that it is unlikely
that proline isomerization contributes significantly to the differences
in folding rates between PmMDH and EcMDH.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Double jump experiments to determine whether
proline cis-trans isomerization is a major
rate-limiting step for PmMDH renaturation. The spontaneous
renaturation rates and yield of active PmMDH are compared under various
denaturation times. Denaturations of PmMDH are performed for 30 s
( ) and 2 h ( ). Although there is a slight enhancement of the
renaturation rate, this rate is still considerably slower than the
renaturation profile of active EcMDH ( ) even after this isozyme is
denatured for 2 h.
|
|
Effect of Glycerol on the Refolding of EcMDH and PmMDH--
A
number of investigators have suggested that increased solution
viscosities can influence the observed folding rates by slowing the
intramolecular chain collapse or domain pairing (for review, see Ref.
30), associative kinetics, and monomer folding. However, these same
solutes used to increase solution viscosity can also influence the
solvation states of proteins, usually by stabilizing the native fold
and thus affecting folding transition states. As a result, the opposite
effect of enhanced protein folding rates can also occur. A number of
studies indicate that the protein folding kinetics is accelerated when
various polyol osmolytes are present (15, 16). Because both MDH
isozymes can refold and assemble at 20 °C, we decided to examine
what effect an increasing polyol (glycerol) concentration might have on
the refolding and assembly reactions of both EcMDH and PmMDH. Polyols
such as glycerol do not affect the activities of these enzymes and are
considered to be "compatible" solutes (31). Indeed, we found that
the specific activities of both dehydrogenases are virtually identical
in the presence or absence of glycerol (data not shown).
At glycerol concentrations of up to 35% (4 M), the
refolding and reassembly rates of EcMDH at 20 °C were virtually
unaffected (Fig. 4A). In stark
contrast, the reassembly and reactivation of PmMDH were increased
dramatically under the same conditions (Fig. 4B). The
renaturation profile is influenced by the concentration of glycerol
present in the renaturation mixture (Fig.
5A and Table I). The optimal
concentration range for glycerol-enhanced
renaturation rates and yields was from 20 to 35% glycerol. At higher
glycerol concentrations (>50%), the reactivation rates were slower,
but the overall yields were higher than those observed in the absence of glycerol (Fig. 5A). Furthermore, including glycerol in
the renaturation mixture at the "nonpermissive" physiological
temperature of 37 °C also accelerated the refolding and assembly
reaction with the refolding yields as high as ~80% (Fig.
5B and Table I). Under these temperature conditions, which
are nonpermissive in the absence of glycerol, the optimal renaturation
rates were also observed around glycerol concentrations of about 35%
(Fig. 5B).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Spontaneous renaturation of EcMDH and PmMDH
with ( ) and without ( ) 35% glycerol at 20 °C.
The spontaneous renaturation rate profiles and yields of EcMDH
(panel A) and PmMDH (panel B) are performed at
monomeric concentrations of 0.1 µM. The renaturation
profiles demonstrate that the renaturation of PmMDH yields and rates is
enhanced significantly with glycerol, whereas EcMDH shows little change
in the renaturation profiles (single exponential fits
k = 0.06 s 1 for 0% glycerol ( )
versus 0.02 s 1 for 35% glycerol ( )). The
kinetic parameters resulting in the best fit to the renaturation
profiles of PmMDH are listed in Table I.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Spontaneous renaturation of PmMDH with
various concentrations of glycerol. 0.1 µM PmMDH
subunits are renatured in the presence of various concentrations of
glycerol (v/v). Panel A, spontaneous renaturation of PmMDH
with different concentrations of glycerol at permissive temperatures:
0% glycerol ( ), 7% glycerol ( ), 20% ( ), 35% ( ), 50%
( ), 60% ( ), and 70% ( ) glycerol. At 20 °C, the fastest
renaturation profile is found at 20% glycerol. The highest yield is
found when 35% glycerol is present. Panel B, spontaneous
renaturation of PmMDH with different concentrations of glycerol at
nonpermissive temperatures (37 °C): 0% ( ), 20% ( ), 35%
( ), and 50% glycerol ( ). PmMDH renaturation rates increase as
the glycerol concentration is increased from 0 to 35% (v/v). The
spontaneous recovery rates show a slight decrease as the glycerol
concentration is raised from 35 to 50%. The kinetic constants are
listed in Table I.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic fits to the spontaneous PmMDH renaturation profile with various
concentrations of glycerol using Ranson model (21)
|
|
Change in the Chaperonin Requirements for PmMDH Folding in the
Presence of Glycerol--
When glycerol was added to the renaturation
solution, the requirement for GroES was relaxed. Denatured PmMDH could
now be substantially reactivated in 35% glycerol with GroEL and ATP
instead of just GroEL, GroES, and ATP (Fig.
6). It is important to note that the high
affinity chaperonin (GroEL alone) can still arrest the renaturation of
PmMDH completely (Fig. 6). This observation indicates that in the
presence of glycerol, the folding intermediates of PmMDH still have a
high affinity for GroEL and can form tight, arrested complexes with
GroEL. But more importantly, the spontaneous folding and the
GroEL·GroES·ATP reactivation profiles are virtually identical in
the presence of glycerol (Fig. 6 and Table I). Curiously, the folding
and assembly of PmMDH in the presence of the GroE chaperonins were
faster with glycerol than without it (Table I).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
The GroE chaperonin stringency for PmMDH
renaturation is diminished in the presence of 35% glycerol at
37 °C. The refolding buffer is composed of 50 mM triethanolamine hydrochloride, 50 mM KCl, 20 mM MgCl2, and 10 mM dithiothreitol
at pH 7.5. The final PmMDH subunit concentration is 0.1 µM. The chaperonin concentrations are 1 µM
GroEL oligomer, 2 µM GroES oligomer, and 5 mM
ATP. Renaturation profiles shown are in the absence of chaperonins
( ), the presence of GroEL ( ), the presence of GroEL and ATP
( ), and in the presence of GroEL, GroES, and ATP ( ).
Interestingly, in the presence of glycerol, the renaturation kinetic
profiles of spontaneous folding and folding with GroEL, GroES, and ATP
are almost identical, and the renaturation of PmMDH in the presence of
GroEL is severely arrested. The kinetic constants are listed in Table
I.
|
|
Given this observation, we wanted to test whether the PmMDH folding
intermediates, generated in the presence of glycerol, would even
interact with the activated chaperonin complex (GroEL·GroES·ATP). To observe this initial interaction, a rapid immunoprecipitation technique with anti-GroEL antibodies was employed. A similar protocol was used to measure the rates at which a renaturing protein commits to
fold to the native state in the presence of chaperonins (25). These
experiments have shown that the addition of a large excess of GroEL
antibody within 5-15 s after initiating the chaperonin-mediated folding reaction was sufficient to precipitate the chaperonin-substrate complex from the solution completely
(24).2
As expected, the immunoprecipitation reactions at 15 s completely
removed any recoverable PmMDH activity from the supernatant when
glycerol was absent from renaturation solutions containing the GroE
chaperonins (Fig. 7). In the absence of
glycerol, the precipitation of activated GroEL complexes after 2 h
showed the expected amount of recovered PmMDH activity. In contrast, in
the presence of activated GroE and glycerol, antibodies failed to remove all of the PmMDH activity from the renaturation solution. Nearly
40% of the recovered PmMDH was retained in the supernatant upon the
immediate (within 15 s) and rapid removal of the chaperonin by
immunoprecipitation, whereas in control experiments, the addition of
anti-GroEL antibodies containing a spontaneous refolding mixture in
glycerol showed a similar amount PmMDH activity recovery (Fig. 7). When
the high affinity form of GroEL was used instead of the activated
chaperonin complex in the presence of glycerol, very little PmMDH
activity was recovered in the supernatant after GroEL immunoprecipitation. This indicates that the PmMDH monomers still bind
to the chaperonin in the presence of glycerol and refolding buffer. The
addition of ATP and GroES to the precipitated GroEL·PmMDH complexes
resulted in substantial release and refolding of the protein
substrate,3 indicating that
the immunoprecipitated complex is still active. Taken together, our
immunoprecipitation experiments indicate that the interaction between
the folding intermediates of PmMDH and the activated chaperonin is
decreased substantially when PmMDH refolds in the presence of 35%
glycerol.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 7.
PmMDH commitment to the active state in the
presence of different combinations of the GroE chaperonin folding
system with (open bar) and without (solid
bar) 35% glycerol. The PmMDH subunit concentration in
all experiments is 0.1 µM. In the absence of glycerol,
PmMDH combines rapidly with GroEL, GroEL, and ATP, or the full
complement of GroEL, GroES, and ATP, and is removed from the folding
medium. After 2 h, only the full complement (far right
panel) shows significant activity. In the presence of glycerol,
GroEL alone arrests PmMDH renaturation (from left,
second panel). Although PmMDH folds with GroEL and ATP
(third panel), substantial amounts of PmMDH still
immunoprecipitate upon the immediate addition of anti-GroEL antibodies.
In contrast, with glycerol present, almost equivalent amounts of PmMDH
commit to reactivation in the absence (far left panel) and
presence (far right panel) of the activated chaperonin
complex (GroEL, GroES, ATP) when the immunoprecipitation is carried out
at within 15 s and 2 h after initiating renaturation.
|
|
Glycerol Prevents Deleterious Aggregation of PmMDH--
In
addition to aiding in the reactivation of PmMDH, glycerol also prevents
deleterious aggregation of PmMDH (Fig.
8). At a nonpermissive temperature
(37 °C), 90o light scattering measurements showed that
the addition of 35% glycerol to the refolding mixture of PmMDH
prevented any detectable large scale aggregation. Regardless of the
mechanism of aggregation prevention, glycerol allowed PmMDH folding
intermediates to reactivate to a high yield (~80%). These high
levels of reactivation are observed even at MDH concentrations as high
as 1 µM. Horowitz and co-workers (32) have also shown
that glycerol can also prevent large scale rhodanese aggregation.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 8.
Spontaneous renaturation of PmMDH at
37 °C monitored by 90 ° light
scattering. The formation of large protein aggregates during the
spontaneous renaturation of PmMDH can be prevented when 35% glycerol
is present in the refolding solution. The final PmMDH subunit
concentration is 1 µM (subunit).
|
|
Glycerol Jump Experiments with GroEL·PmMDH
Complexes--
Because the chaperonin requirements for PmMDH become
less stringent when glycerol is present, this raised the following
question. Will a GroEL·PmMDH complex formed in the presence of
glycerol retain a nonstringent chaperonin requirement if this system is switched rapidly from a glycerol-containing solution to one without glycerol? Starting with an arrested PmMDH·GroEL complex, a jump from
low (0%) to high glycerol (35%) solution concentrations showed that
PmMDH was released from GroEL as soon as ATP was added, and it refolded
to an active state (Fig. 9). In fact, if
the jump solution contained ATP, the reactivation kinetic profile was
identical to that when ATP was added to a GroEL·PmMDH complex that
was formed under high glycerol conditions. However, if the
chaperonin·PmMDH complex was formed in the presence of 35% glycerol
and the solution conditions were jumped rapidly to lower glycerol
concentrations (3.5%) in the presence of ATP, reactivation of PmMDH
was no longer observed (Fig. 9). Only when GroES was included in the
refolding mixture at low glycerol concentrations could PmMDH once again reactivate (data not shown). These experiments indicated that the
glycerol-dependent shift in chaperonin stringency is less than 3-5 s (typical manual mixing times).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 9.
The final renaturation environment determines
the stringency of the GroE chaperonins for PmMDH at
37 °C. The kinetic profiles represent the recovery
of PmMDH activity from GroEL·PmMDH complexes after a 10-s allowance
of complex formation before either a 0-35% ( ) or 35-3.5% ( )
glycerol jump is initiated. Similar profiles are obtained if the
glycerol jump is performed on the GroEL·PmMDH complex after the
complex is formed and incubated in the starting solution for 1 h.
The final yields for the successful jumps (35% glycerol final
concentration) are similar for short and long delays. Only when the
final renaturation environment contains 35% glycerol will the GroE
chaperonin stringency requirements for renaturing PmMDH diminish from
the full supplement of GroEL, GroES, and ATP to only GroEL and
ATP.
|
|
Irreversible Misfolding Experiments with Glycerol and
Chaperonins--
During spontaneous refolding at 37 °C, refolding
subunits of PmMDH partition preferentially to an irreversibly misfolded
species. Clarke and co-workers (21, 32) have shown that the folding competence of the PmMDH-folding intermediate decays at a particular rate, the reaction is second order, and that this rate can be measured
easily (21, 32). Rate measurements for PmMDH decay were accomplished by
initiating the refolding reaction and then adding the activated
chaperonin system (GroEL·GroES·ATP) at variable delay times (0-60
s). For each time point, the maximum rescued activity was measured, and
the irreversible misfolding kinetic profile was determined from the
declining reactivation amplitude. Previous experimental results showed
that there can be significant differences in the irreversible
misfolding kinetic profiles of some proteins when the nature of the
rescuing chaperonin is switched from the high affinity (GroEL alone)
form to the fully activated (GroEL·GroES·ATP) chaperonin complex
(33). These previous results suggested that a broader population of
folding intermediates partitions onto a high affinity (nucleotide-free)
GroEL chaperonin. Because glycerol or activated GroE (as well as GroEL
alone) inhibits PmMDH misfolding, we compared the irreversible
misfolding kinetics of PmMDH when either glycerol or the activated
chaperonin complexes were added to rescue folding intermediates. We
wanted to test whether glycerol, like the proposed action of the Hsp104
molecular chaperone class, could reverse or disrupt aggregates. Our
data showed that the irreversible misfolding kinetics and amplitude profiles at set PmMDH concentrations were identical when either 35%
glycerol or the activated chaperonins was used to rescue the transient
folding intermediates (Fig. 10).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 10.
Kinetics of irreversible misfolding of PmMDH
with 35% glycerol and GroEL·GroES-(ATP)7 at
37 °C. The irreversible misfolding kinetics of PmMDH
with 35% glycerol ( ) and with the nucleotide-activated chaperonin
complex, GroEL·GroES-(ATP)7 ( ), are essentially
identical. Both sets of data can be fit to a double exponential decay
function with virtually identical rate constants for
k1 = 0.48 ± 0.6 s 1 and
k2 = 0.06 ± 0.008 s 1 or
0.01 ± 0.010 s 1 for activated chaperonin and 35%
glycerol, respectively. The final oligomer concentrations of GroEL and
GroES were 1 and 2 µM. The ATP and PmMDH concentrations
were 5 mM and 0.1 µM (monomer),
respectively.
|
|
Concentration Dependence of PmMDH Renaturation in
Glycerol--
The kinetics and concentration dependences of the
reassembly and reactivation of both the porcine cytoplasmic and
mitochondrial MDH isozymes were originally studied by Jaenicke and
co-workers (34). These investigators found that the reactivation of
cytoplasmic MDH follows first order kinetics and is independent of
concentration. In contrast, the mitochondrial isozyme (PmMDH)
reactivation was found to be concentration-dependent. One model
used to fit the data assumes that the monomer assembles rapidly into an
inactive dimer that undergoes a unimolecular reaction before an active dimer is formed, a bi-unimolecular mechanism (34). Because there is an
enhanced renaturation of PmMDH in glycerol, we set up experiments to
determine whether the molecular mechanism of PmMDH assembly changes in
the presence of this osmolyte to be independent of protein concentration.
The easiest way to determine whether glycerol affects the mechanism of
the kinetic processes is to carry out the renaturation of PmMDH in 35%
glycerol at two different concentrations (Fig. 11). We found that there was a
noticeable concentration dependent increase in the renaturation
kinetic profiles of PmMDH in the presence of glycerol. These results
suggest that the mechanism of this reaction still depends on a second
order process.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 11.
In the presence of 35% glycerol, PmMDH
shows concentration-dependent renaturation rates. At the
final PmMDH subunit concentrations of 0.1 µM ( ) and
0.025 µM ( ), the renaturation profile is clearly more
rapid as the initial PmMDH concentration increases.
|
|
The Effects of Other Folding Additives on PmMDH
Renaturation--
To determine whether other osmolytes may also
enhance the renaturation reaction of PmMDH, other natural osmolytes
such as trimethylamine N-oxide (TMAO), betaine, and sucrose were added to the renaturation mixture at 37 °C (Table
II). At 37 °C, where PmMDH
renaturation is nonpermissive, all of the osmolytes tested facilitated
substantial folding of PmMDH (>30%). Betaine and glycerol were
similar in their ability to enhance renaturation of PmMDH. However, the
polyol osmolytes (sucrose and glycerol) were the only additives that
were able to change the chaperonin stringency for PmMDH folding from
GroEL, GroES, and ATP to GroEL and ATP. No PmMDH reactivation are
observed when either betaine or TMAO are present with GroEL and ATP
alone (Table II). With these latter two osmolytes, reactivation from
GroEL·PmMDH was only observed when GroES and ATP were added together
(last column in Table II).
View this table:
[in this window]
[in a new window]
|
Table II
Renaturation of PmMDH with other osmolytes
The data show that other commonly used osmolytes will facilitate the
renaturation of PmMDH at nonpermissive folding temperatures (37 °C).
The folding conditions were the same as described under "Materials
and Methods."
|
|
 |
DISCUSSION |
It has been demonstrated repeatedly that homologs in protein folds
do not translate into similar protein interactions with the GroE
chaperonins (4-6). Data collected by Frieden and Clark (35, 36)
strongly suggest that the differences in folding kinetics of DHFR
isozymes determine chaperonin interactions. Based on structural
differences these investigators also suggested that additional
unstructured loop regions in the protein determined chaperonin
interactions (6). However, Fenton and Horwich (8) suggest that these
unstructured regions may be irrelevant to the interaction between GroEL
and DHFR, and it is the folding core that is responsible for the
kinetic control of chaperonin-substrate interaction (8). Regardless of
the exact mechanism of interaction, these experiments with DHFR
homologs indicate that folding speed may be a crucial parameter
governing chaperonin-protein substrate interactions.
It is important to note that DHFR falls into the class II substrate
category for chaperonin interaction (37). These substrates do not
require the complete contingent of the chaperonins (i.e. GroEL and GroES) to fold (38). The homologous malate dehydrogenase isozymes, EcMDH and PmMDH, used in our work naturally fold in the
presence of group I chaperonin (Cpn60/Cpn10) systems in
vivo. Because PmMDH absolutely requires the entire set of GroE
chaperonins and ATP to mediate its folding under nonpermissive in
vitro conditions, this in vitro substrate is classified
as a potential class III substrate (37, 38). Based on the identities of
a broad set of chaperonin substrates isolated by coimmunoprecipitation
experiments from E. coli cell extracts, Hartl and co-workers
(7) suggested that the  fold, with a particular reference to the
 fold of PmMDH, correlates with potential chaperonin substrate
identification. Our experiments have shown that unlike its structurally
homologous porcine mitochondrial counterpart, E. coli MDH
folds very rapidly without the assistance of the GroE chaperonins and
does not appear to interact with any of the physiologically relevant
activated forms of the GroE chaperonins. Our results strongly suggest
that structural folds cannot be used alone to identify potential class III chaperonin substrates. Based on our results, however, we do predict
that a substantial portion of the potential E. coli
chaperonin substrates identified by Houry et al. (7) should
have slower folding/assembly kinetics than the other E. coli
proteins that do not require chaperonin assistance to fold.
Widmann and Christen (14) have found that the folding rates of
three different oligomeric E. coli proteins are much faster than their mitochondrial homologs. These investigators have found that
the mitochondrial aspartate aminotransferase folds slower than its
E. coli counterpart because of cis-trans proline
isomerization. Furthermore, these investigators also note that the
EcMDH folds faster than PmMDH at 25 °C. Unlike mitochondrial
aspartate aminotransferase, our results suggest that proline
isomerization is not the rate-limiting step for renaturation of PmMDH.
In addition, if proline isomerization was the rate-limiting step, one
would also predict that isomerization will still retard the folding
rate even when folding enhancers such as glycerol are added to the
refolding mixture. If so, the renaturation rates for the short pulsed
denatured PmMDH (i.e. short incubation times in the
denaturant) with glycerol could be comparable with those rates observed
with EcMDH renaturation. However, contrary to this expectation,
variable denaturation times of PmMDH did not result in disparate
renaturation kinetics in the presence of glycerol (data not shown).
Our results indicate that the renaturation of PmMDH is enhanced by the
addition of glycerol at all temperatures tested and that the chaperonin
requirements diminish in its presence (39). 90o light
scattering experiments have confirmed that the addition of glycerol
inhibits the large scale off-pathway aggregation reaction. We initially
thought that the aggregation prevention might be sufficient to
facilitate the rapid renaturation of PmMDH. It has been shown in
silico that a small addition of urea at nondenaturing concentrations may prevent early aggregation of some proteins (40). To
test whether early observed aggregation is the main reason for slow
PmMDH refolding, we added a small amount of nondenaturing urea during
spontaneous folding of PmMDH. As expected, urea inhibits the
accumulation of large aggregates of malate dehydrogenase (data not
shown). However, unlike glycerol, low urea concentrations could not
influence the spontaneous reactivation profiles of PmMDH at any of the
temperatures tested. Urea also destabilizes the renaturation of PmMDH
in the presence of glycerol and reflects the opposing effects that
osmolytes and denaturants have on protein stability (41). Thus, it
appears that osmolytes may be acting at a different step in the folding
reaction (i.e. on pathway reaction landscape) to facilitate renaturation.
One interesting result came from our comparisons of the irreversible
misfolding kinetics of MDH with 35% glycerol or activated GroE. By
delaying the addition of the activated chaperonin complex or glycerol
after initiating a PmMDH reactivation, we could obtain comparative
irreversible kinetic profiles prior to chaperonin- or
glycerol-dependent rescue and could determine the time it
takes for PmMDH to partition into an irreversible misfolded
conformation. If glycerol, like the Hsp100 classes, could affect or
disrupt the aggregation reaction prior to the commitment to
irreversible misfolding, a delayed addition of glycerol should yield a
different kinetic decay profile (i.e. slower decline in
activity than that observed with the chaperonin). Contrary to this
prediction, the irreversible misfolding kinetics for both systems was
identical. The observed similarity in rates may indicate that glycerol
and the chaperonin are rescuing the same intermediate populations from misfolding.
Some aspects of the glycerol-assisted folding of PmMDH do mirror the
chaperonin-assisted folding reaction. For both systems, glycerol
accelerates the apparent PmMDH reactivation, and large scale
aggregation is prevented. If the Ranson kinetic scheme for PmMDH
refolding (21) truly reflects the molecular events, the fit to our data
indicates that the collapse or accumulation of folded monomers to
assembly-competent forms is accelerated or enhanced when glycerol is
present (Table I). Apparently, this glycerol-dependent
collapse may be more substantial than the increase in
assembly-competent monomers observed when chaperonins alone are used to
facilitating folding (Table I). However, we must be cognizant of the
fact that we are only examining the renaturation profiles and that the
molecular events preceding the association and renaturation
(i.e. the folding reaction toward an assembly-competent PmMDH monomer) cannot be determined directly by the analysis presented here. The PmMDH reactivation reflects the final step in the formation of the native active dimer (21, 34). With glycerol present, the
chaperonin-dependent PmMDH reactivation occurs with ATP
alone instead of with ATP and GroES combined. Glycerol jump experiments demonstrate that the GroEL·PmMDH complex relaxes very rapidly when the folding conditions are shifted quickly between nonpermissive and permissive folding environments. It appears that glycerol inhibits
off-pathway large scale aggregation, and its presence influences the
folding of the bound intermediate. The effects of glycerol are
certainly not limited to the substrate itself. Curiously, glycerol
appears to affect the chaperonin itself by stabilizing this oligomer
against denaturation. Titrations show that the hydrophobic dye binding
reactions involving 1,1 bi(4anilino)naphthalene-5,5'-disulfonic acid approaches saturation at lower 1,1 bi(4-anilino)naphthalene-5,5'-disulfonic acid
concentrations.4
We have observed that various osmolytes also accelerate PmMDH
reactivation with or without chaperonins. In addition, with glycerol
present, the interaction between activated chaperonin and refolding
PmMDH subunits cannot be detected by rapid immunoprecipitation. Given
the observed influence of glycerol on spontaneous PmMDH folding, we
tend to favor the explanation that osmolytes, particularly glycerol,
primarily influence the folding of the PmMDH subunits. Indeed, other
investigators have provided evidence suggesting that osmolytes may
enhance folding because these compounds may decrease the activation
energy barrier for folding, leading to a more rapid polypeptide
collapse (15, 42).
Even though the molecular basis behind the glycerol-induced enhancement
of the PmMDH renaturation rates cannot be determined by the data
presented here, it is clear that this enhancement leads to a reduction
in the chaperonin requirements. The accumulated literature data support
the notion that some polyols such as sucrose and glycerol can stabilize
proteins by shifting the equilibrium toward more compact or collapsed
states, perhaps explaining the observed increase in rates of the
apparent folding reactions (15, 16). Likewise, a reduction in the
population of transient expanded states may also diminish the available
species that lead to off-pathway aggregation (43). Consequently, this
decline in the population of transient expanded states may explain why
the activated chaperonin no longer interacts very well with the
refolding PmMDH monomers.
Although the exact mechanisms governing this accelerated folding are
not clear, polyols may decrease the volume of the transient state
intermediate (15). By measuring specific transfer free energies of
amino acid and peptide backbone between aqueous and osmolyte containing
solutions, Bolen and co-workers (44, 45) have uncovered a possible
molecular explanation for osmolyte-induced stabilization. Experimental
evidence suggests that the denatured and native states of proteins are
both destabilized by osmolytes. However, Bolen's thermodynamic data
indicate that the destabilization of the denatured state far exceeds
the destabilization free energy of the native state because the peptide
backbone solubility decreases in osmolyte solutions. This disparity in
destabilization results in a net increase in the free energy of
stabilization (44, 45). If we extend this property to the energy levels
of folding intermediates and transition states, an acceleration in
folding can result primarily from a destabilization of the intermediate
state, a stabilization (or smaller destabilization) of the more native
and compact transition states, or osmolytes may affect both states. The
bottom line is that any subsequent decrease in the activation energy
barriers (the folding landscapes) will result in faster folding rates
(46, 47). With glycerol present, faster folding of the PmMDH
intermediate toward an assembly-competent, native-like monomer may
result from any decrease in the activation energy differences between
folded intermediates and transition states. Using the kinetic model
presented by Clarke and co-workers (21, 22), our analysis suggests that there may be an increase in the microscopic rate constant for the
collapse toward an assembly-competent monomer by at least 1-4 orders
of magnitude (Table I). Unfortunately, the analysis performed herein
does not provide any information about the energy levels of the
transition states. However, any resulting increase in the concentration
of assembly-competent monomers will naturally lead to an increase in
apparent rate of the bimolecular assembly reaction and may bypass the
need for any chaperonin assistance.
The effect of glycerol on the entire reaction mechanism also shows that
the off-pathway kinetics has changed. Clarke and co-workers (21, 22)
have suggested that the chaperonins influence the partitioning
reactions of off-pathway intermediates. The fit of our data to the
model predicts that the aggregation reaction will also decrease by an
order of magnitude (see k5, Table I). The slower
aggregation reaction coupled with the rapid collapse to assembly-competent monomers correlates with the observed loss in large
aggregate formation during spontaneous refolding (Fig. 8). The effect
of glycerol on renaturation of PmMDH may not be specific because we
also observe an accelerated and/or enhanced folding (37 °C) of PmMDH
by other osmolytes such as betaine, sucrose, and TMAO. Curiously,
betaine and TMAO do not change the chaperonin requirements when
refolding PmMDH binds to the high affinity chaperonin (Table II). Here
again is another situation in which the GroES requirement is not
dictated by "permissivity" of the folding conditions (17, 39).
Because various osmolytes show differential interactions with proteins
and change the chaperonin requirements (48-50), our future studies
will examine how betaine and TMAO affect PmMDH folding kinetics.
In summary, our experimental results support the notion that the
folding rates, rather than the structural identity or folding class of
chaperonin substrates, are the key determinants that dictate
interactions between transient folding intermediates populations and
chaperonins (9, 10). The folding intermediate structures of homologous
proteins that require chaperonins to fold are predicted to have longer
lifetimes and/or slower on-pathway folding rates. In addition, our
studies indicate that some osmolytes will profoundly influence the
chaperonin requirements and that osmolytes certainly may influence the
folding kinetics and stabilization of on-pathway protein folding intermediates.
 |
ACKNOWLEDGEMENT |
We thank Dr. Paul Voziyan for a critical
review of this manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM49309 (to M. T. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Contributed to more than 90% of the work presented in this paper.
Present address: Abbott Laboratories, ADD Hybridoma Research, 100 Abbott Park, Abbott Park, IL 60064.
§
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7421. Tel.: 913-588-6940; Fax: 913-588-7440; E-mail: mfisher1@kumc.edu.
Published, JBC Papers in Press, September 10, 2001, DOI 10.1074/jbc.M106693200
2
M. T. Fisher, unpublished observations.
3
C.-M. Low, K. E. Smith, and M. T. Fisher,
unpublished results.
4
P. A. Voziyan and M. T. Fisher (2002)
Arch. Biochem. Biophys., in press.
 |
ABBREVIATIONS |
The abbreviations used are:
DHFR, dihydrofolate
reductases;
MDH, malate dehydrogenase;
EcMDH, E. coli malate
dehydrogenase;
PmMDH, porcine mitochondrial malate dehydrogenase;
TMAO, trimethylamine N-oxide.
 |
REFERENCES |
| 1.
|
Roseman, A. M.,
Chen, S.,
White, H.,
Braig, K.,
and Saibil, H. R.
(1996)
Cell
87,
241-251
|
| 2.
|
Kad, N. M.,
Ranson, N. A.,
Cliff, M. J.,
and Clarke, A. R.
(1998)
J. Mol. Biol.
278,
267-278
|
| 3.
|
Horovitz, A.
(1998)
Curr. Opin. Struct. Biol.
8,
93-100
|
| 4.
|
Staniforth, R. A.,
Cortes, A.,
Burston, S. G.,
Atkinson, T.,
Holbrook, J. J.,
and Clarke, A. R.
(1994)
FEBS Lett.
344,
129-135
|
| 5.
|
Mattingly, J. R.,
Iriarte, A.,
and Martinez-Carrion, M.
(1993)
J. Biol. Chem.
268,
26320-26327
|
| 6.
|
Clark, A.,
Clay, E. H.,
and Frieden, C.
(1996)
Biochemistry
35,
5893-5901
|
| 7.
|
Houry, W. A.,
Frishman, D.,
Eckerskorn, C.,
Lottspeich, F.,
and Hartl, F. U.
(1999)
Nature
402,
147-154
|
| 8.
|
Fenton, W. A.,
and Horwich, A. L.
(1997)
Protein Sci.
6,
743-760
|
| 9.
|
Randall, L. L.,
and Hardy, S. J. S.
(1995)
Trends Biochem. Sci.
20,
65-69
|
| 10.
|
Viitanen, P. V.,
Gatenby, A. A.,
and Lorimer, G. H.
(1992)
Protein Sci.
1,
363-369
|
| 11.
|
Clark, A. C.,
and Frieden, C.
(1999)
J. Mol. Biol.
285,
1765-1776
|
| 12.
|
Clark, A. C.,
and Frieden, C.
(1999)
J. Mol. Biol.
285,
1777-1788
|
| 13.
|
Shtilerman, M.,
Lorimer, G.,
and Englander, S. W.
(1999)
Science
284,
822-825
|
| 14.
|
Widmann, M.,
and Christen, P.
(2000)
J. Biol. Chem.
275,
18619-18622
|
| 15.
|
Frye, K. J.,
and Royer, C. A.
(1997)
Protein Sci.
6,
789-793
|
| 16.
|
Ladurner, A. G.,
and Fersht, A. R.
(1999)
Nat. Struct. Biol.
6,
28-31
|
| 17.
|
Voziyan, P. A.,
and Fisher, M. T.
(2000)
Protein Sci.
9,
2405-2415
|
| 18.
|
Eisenstein, E.,
Reddy, P.,
and Fisher, M. T.
(1998)
Methods Enzymol.
290,
119-135
|
| 19.
|
Fisher, M. T.
(1992)
Biochemistry
31,
3955-3963
|
| 20.
|
Fisher, M. T.
(1994)
J. Biol. Chem.
269,
13629-13636
|
| 21.
|
Ranson, N. A.,
Dunster, N. J.,
Burston, S. G.,
and Clarke, A. R.
(1995)
J. Mol. Biol.
250,
581-586
|
| 22.
|
Ranson, N. A.,
Burston, S. G.,
and Clarke, A. R.
(1997)
J. Mol. Biol.
266,
656-664
|
| 23.
|
Brandts, J. F.,
Halvorson, H. R.,
and Brennan, M.
(1975)
Biochemistry
14,
4953-4963
|
| 24.
|
Schmid, F. X.
(1986)
Methods Enzymol.
131,
70-82
|
| 25.
|
Fisher, M. T.,
and Yuan, X.
(1994)
J. Biol. Chem.
269,
29598-29601
|
| 26.
|
Hall, M. D.,
Levitt, D. G.,
and Banaszak, L. J.
(1992)
J. Mol. Biol.
226,
867-882
|
| 27.
|
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132
|
| 28.
|
Roderick, S. L.,
and Banaszak, L. J.
(1986)
J. Biol. Chem.
261,
9461-9464
|
| 29.
|
Miller, A. D.,
Maghlaoui, K.,
Albanese, G.,
Kleinjan, D. A.,
and Smith, C.
(1993)
Biochem. J.
291,
139-144
|
| 30.
|
Jacob, M.,
and Schmid, F-X.
(1999)
Biochemistry
38,
13773-13779
|
| 31.
|
Yancey, P. H.,
Clark, M. E.,
Hand, S. C.,
Bowlus, R. D.,
and Somero, G. N.
(1982)
Science
217,
1214-1222
|
| 32.
|
Panda, M.,
Gorovitzs, B. M.,
and Horowitz, P. M.
(2000)
J. Biol. Chem.
275,
63-70
|
| 33.
|
Voziyan, P. A.,
Tieman, B. C.,
Low, C.-M.,
and Fisher, M. T.
(1998)
J. Biol. Chem.
273,
25073-25078
|
| 34.
|
Jaenicke, R.,
Rudolph, R.,
and Heider, I.
(1979)
Biochemistry
18,
1217-1223
|
| 35.
|
Clark, A. C.,
and Frieden, C.
(1997)
J. Mol. Biol.
268,
512-525
|
| 36.
|
Frieden, C.,
and Clark, A. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5535-5538
|
| 37.
|
Ewalt, K. L.,
Hendrick, J. P.,
Houry, W. A.,
and Hartl, F. U.
(1997)
Cell
90,
491-500
|
| 38.
|
Netzer, W. J.,
and Hartl, F. U.
(1998)
Trends Biochem. Sci.
23,
68-73
|
| 39.
|
Schmidt, M.,
Buchner, J.,
Todd, M. J.,
Lorimer, G. H.,
and Viitanen, P. V.
(1994)
J. Biol. Chem.
269,
10304-10311
|
| 40.
|
Camacho, C. J.,
and Thirumalai, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6369-6372
|
| 41.
|
Liu, Y.,
and Bolen, D. W.
(1995)
Biochemistry
34,
12884-12891
|
| 42.
|
Qu, Y.,
Bolen, C. L.,
and Bolen, D. W.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9266-9273
|
| 43.
|
Kendrick, B. S.,
Carpenter, J. F.,
Cleland, J. L.,
and Randolph, T. W.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14142-14146
|
| 44.
|
Wang, A.,
and Bolen, D. W.
(1997)
Biochemistry
36,
9101-9108
|
| 45.
|
Baskakov, I.,
and Bolen, D. W.
(1998)
J. Biol. Chem.
273,
4831-4834
|
| 46.
|
Todd, M. J.,
Lorimer, G. A.,
and Thirumalai, D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
4030-4035
|
| 47.
|
Dill, K. A.,
and Chan, H. S.
(1997)
Nat. Struct. Biol.
4,
10-19
|
| 48.
|
Voziyan, P.,
Jadav, L.,
and Fisher, M. T.
(2000)
J. Pharm. Sci.
89,
1036-1045
|
| 49.
|
Courtenay, E. S.,
Capp, M. W.,
Anderson, C. F.,
and Record, M. T.
(2000)
Biochemistry
39,
959-976
|
| 50.
|
Weatherly, G. T.,
and Pielak, G. J.
(2001)
Protein Sci.
10,
12-16
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Stan, B. R. Brooks, G. H. Lorimer, and D. Thirumalai
Residues in substrate proteins that interact with GroEL in the capture process are buried in the native state
PNAS,
March 21, 2006;
103(12):
4433 - 4438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Mishra, R. Seckler, and R. Bhat
Efficient Refolding of Aggregation-prone Citrate Synthase by Polyol Osmolytes: HOW WELL ARE PROTEIN FOLDING AND STABILITY ASPECTS COUPLED?
J. Biol. Chem.,
April 22, 2005;
280(16):
15553 - 15560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Khor, M. T. Fisher, and C. Schoneich
Potential Role of Methionine Sulfoxide in the Inactivation of the Chaperone GroEL by Hypochlorous Acid (HOCl) and Peroxynitrite (ONOO-)
J. Biol. Chem.,
May 7, 2004;
279(19):
19486 - 19493.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|